BCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

Blood Cancer Journal, Published online: 11 December 2023; doi:10.1038/s41408-023-00955-yBCMA-targeted bortezomib nanotherapy improves therapeutic efficacy, overcomes resistance, and modulates the immune microenvironment in multiple myeloma

https://www.nature.com/articles/s41408-023-00955-y

Source: Blood Cancer Journal - December 11, 2023 Category: Hematology Authors: Debasmita Dutta Jiye Liu Kenneth Wen Keiji Kurata Mariateresa Fulciniti Annamaria Gulla Teru Hideshima Kenneth C. Anderson Source Type: research